praziquantel has been researched along with Neglected Diseases in 50 studies
azinox: Russian drug
Neglected Diseases: Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human schistosomiasis is a neglected tropical disease caused by Schistosoma mansoni, S." | 5.91 | Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis. ( Alwan, SN; LoVerde, PT; McHardy, SF; Rhodes, J; Taylor, AB; Tidwell, M, 2023) |
| "Praziquantel treatment (40 mg/kg) resulted in 96." | 5.51 | Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel. ( Abay, SM; Esmael, A; Kebede, T; Kemal, M; Tadesse, G, 2019) |
| " The source databases used were Science Direct and PubMed/Medline, in the intervals between 2015 and 2021 with the drugs key-words or diseases, like "schistosomiasis", "praziquantel", "malaria", "artesunate", "Chagas' disease", "benznidazole", "filariasis", diethylcarbamazine", "ivermectin", " albendazole"." | 5.22 | Drug associations as alternative and complementary therapy for neglected tropical diseases. ( Alves, LP; Andrade, MC; Barbosa, IDNG; Ferraz, LRM; Rolim, LA; Rolim-Neto, PJ; Sales, VAW; Santos, WMD; Silva, LCPBB; Souza, ML, 2022) |
| "Sustaining high uptake of praziquantel is key for long-term control of schistosomiasis." | 5.20 | Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial. ( Katahoire, A; Muhumuza, S; Nuwaha, F; Olsen, A, 2015) |
| "Many actors responded to the London Declaration which reinforced praziquantel's central role in control and elimination of schistosomiasis whereas access to affordable insulin emerged secondary to framing around prevention and management of diabetes." | 5.05 | Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel. ( Beran, D; Chappuis, F; Wells, N, 2020) |
| "the study had provided evidence of the distribution of schistosomiasis in South Sudan for policy direction and recommended annual preventive chemotherapy with praziquantel in all endemic areas." | 4.12 | Prevalence and factors associated with transmission of schistosomiasis in school-aged children in South Sudan: a cross-sectional study. ( Abe, A; Ajo, JPH; Berta, KK; Bidali, A; Ndenzako, F; Olu, OO; Onyeze, A; Pascale, JR; Senkwe, MN; Sube, J; Yibi, SM, 2022) |
| "The control and elimination of schistosomiasis have over the last two decades involved several strategies, with the current strategy by the World Health Organization (WHO) focusing mainly on treatment with praziquantel during mass drug administration (MDA)." | 4.02 | Rethinking the Top-Down Approach to Schistosomiasis Control and Elimination in Sub-Saharan Africa. ( Bengtson, M; Diehl, JC; Oladepo, O; Onasanya, A; Van Engelen, J, 2021) |
| "The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE), a program focusing on schistosomiasis control in sub-Saharan Africa between 2008 and 2019, investigated ways to improve coverage and efficacy of ongoing chemotherapy programs and concluded that because of continued transmission, mass distribution of praziquantel cannot eliminate the disease without complementary control activities." | 3.96 | Schistosomiasis Consortium for Operational Research and Evaluation: Mission Accomplished. ( Bergquist, NR, 2020) |
| "Praziquantel (PZQ) is widely used in the treatment of several parasitic infections in both humans and animals, and is the first choice in the treatment of Schistosomiasis in humans." | 3.83 | Polymeric Nanostructured Systems for Liquid Formulation of Praziquan-tel: Development and in vitro Assessment. ( Conti, DS; da Rocha, SR; de Campos, VE; Mansur, CR; Ricci-Júnior, E; Silva, JA, 2016) |
| "Clinical schistosomiasis in endemic countries is treated with a single dose of praziquantel per 40 mg/kg body weight." | 3.80 | From a weighing scale to a pole: a comparison of two different dosage strategies in mass treatment of Schistosomiasis haematobium. ( Krantz, I; Mtweve, S; Nordin, P; Poggensee, G, 2014) |
| "Schistosoma mansoni infection is proven to be a major health problem of preschool-age children in sub-Saharan Africa, yet this age category is not part of the schistosomiasis control program." | 2.80 | Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial. ( Nalugwa, A; Nuwaha, F; Olsen, A; Tukahebwa, EM, 2015) |
| "Diagnosis of intestinal schistosomiasis was assessed using single stool sample, double Kato-Katz smear examinations." | 2.77 | Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety. ( Fenwick, A; Kabatereine, NB; Mutumba-Nakalembe, MJ; Navaratnam, AM; Sousa-Figueiredo, JC; Stothard, JR, 2012) |
| "Albendazole chemotherapy was found to be the primary pharmacological treatment to consider in the medical management of CE." | 2.58 | Medical treatment of cystic echinococcosis: systematic review and meta-analysis. ( Alonso-Sardón, M; Belhassen-García, M; Burguillo, FJ; Carpio-Pérez, A; Cordero, M; Lopez-Bernus, A; Muñoz Bellido, JL; Muro, A; Pardo-Lledias, J; Romero-Alegría, Á; Velasco-Tirado, V, 2018) |
| "Currently, the main forms of treatment used for schistosomiasis are praziquantel (PZQ) and oxaminiquine (OXA)." | 2.55 | Schistosomiasis: Drugs used and treatment strategies. ( Aguilera, CSB; Ângelos, MA; da Silva, RMF; de Melo, CG; Fontes, DAF; Neto, PJR; Rolim, LA; Silva, LCPBB; Siqueira, LDP; Timóteo, TRR, 2017) |
| "Human schistosomiasis is a neglected tropical disease caused by Schistosoma mansoni, S." | 1.91 | Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis. ( Alwan, SN; LoVerde, PT; McHardy, SF; Rhodes, J; Taylor, AB; Tidwell, M, 2023) |
| "Schistosomiasis is a neglected tropical disease with more than 200 million new infections per year." | 1.72 | Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects. ( Gallinger, TL; Grevelding, CG; Grünweller, A; Haeberlein, S; Lange-Grünweller, K; Mäder, P; Rennar, GA; Schlitzer, M, 2022) |
| "Schistosomiasis is caused by parasitic blood flukes." | 1.72 | Colonic polyps: a rare clinical manifestation of schistosomiasis (a case report). ( Gatheru, J; Mohamed, A; Orare, K; Rajula, A; Thakkar, M, 2022) |
| " However, there are no published data regarding adverse events associated with these medications." | 1.56 | Schistosomiasis and soil-transmitted helminthiasis preventive chemotherapy: Adverse events in children from 2 to 15 years in Bengo province, Angola. ( Barros, H; Brito, M; Fançony, C; Lemos, M; Moura, S; Nery, SV; Pedro, JM; Sousa, CP, 2020) |
| "Praziquantel treatment (40 mg/kg) resulted in 96." | 1.51 | Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel. ( Abay, SM; Esmael, A; Kebede, T; Kemal, M; Tadesse, G, 2019) |
| "Schistosomiasis has been of concern to local health authorities for most of the last century, and in spite of a lack of effective chemotherapy, the disease was dealt with quite effectively in many endemic countries by snail control and environmental management [1]." | 1.46 | Why reinvent the wheel? Lessons in schistosomiasis control from the past. ( Shiff, C, 2017) |
| "Schistosomiasis is a debilitating neglected tropical disease caused by schistosome worms." | 1.43 | Schistosomiasis therapeutics: whats in the pipeline? ( Mutapi, F; Trainor-Moss, S, 2016) |
| "The recent outbreak of Ebola virus disease (EVD) interrupted mass drug administration (MDA) programs to control and eliminate neglected tropical diseases in Liberia." | 1.43 | Community Attitudes Toward Mass Drug Administration for Control and Elimination of Neglected Tropical Diseases After the 2014 Outbreak of Ebola Virus Disease in Lofa County, Liberia. ( Bogus, J; Bolay, FK; Fischer, K; Fischer, PU; Gankpala, L; Kollie, K; Krentel, A; Weil, GJ, 2016) |
| "Schistosomiasis has been a public health burden in a number of countries across the globe for centuries and probably beyond." | 1.43 | Schistosomiasis elimination by 2020 or 2030? ( Fenwick, A; Jourdan, P, 2016) |
| "Despite attempts to control intestinal schistosomiasis through school-based mass drug administration (MDA) with praziquantel using school teachers in Uganda, less than 30% of the school children take the treatment in some areas." | 1.42 | Understanding low uptake of mass treatment for intestinal schistosomiasis among school children: a qualitative study in Jinja district, Uganda. ( Katahoire, A; Muhumuza, S; Nuwaha, F; Olsen, A, 2015) |
| "Female urogenital schistosomiasis (arising from infection by Schistosoma haematobium, endemic in Africa and the Middle East) may show a variety of lesions in the female genital tract, some of which may be misdiagnosed as viral warts." | 1.42 | A case of female urogenital schistosomiasis presenting as viral warts. ( Samuel, MI; Taylor, C, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 31 (62.00) | 24.3611 |
| 2020's | 19 (38.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva, VBR | 1 |
| Campos, BRKL | 1 |
| de Oliveira, JF | 1 |
| Decout, JL | 1 |
| do Carmo Alves de Lima, M | 1 |
| Ferraz, LRM | 1 |
| Silva, LCPBB | 2 |
| Souza, ML | 1 |
| Alves, LP | 1 |
| Sales, VAW | 1 |
| Barbosa, IDNG | 1 |
| Andrade, MC | 1 |
| Santos, WMD | 1 |
| Rolim, LA | 2 |
| Rolim-Neto, PJ | 1 |
| Ogongo, P | 1 |
| Nyakundi, RK | 1 |
| Chege, GK | 1 |
| Ochola, L | 1 |
| Domoto, F | 1 |
| Kojima, H | 1 |
| Tasaki, H | 1 |
| Rennar, GA | 1 |
| Gallinger, TL | 1 |
| Mäder, P | 1 |
| Lange-Grünweller, K | 1 |
| Haeberlein, S | 1 |
| Grünweller, A | 1 |
| Grevelding, CG | 1 |
| Schlitzer, M | 1 |
| Senkwe, MN | 1 |
| Berta, KK | 1 |
| Yibi, SM | 1 |
| Sube, J | 1 |
| Bidali, A | 1 |
| Abe, A | 1 |
| Onyeze, A | 1 |
| Ajo, JPH | 1 |
| Pascale, JR | 1 |
| Ndenzako, F | 1 |
| Olu, OO | 1 |
| Orare, K | 1 |
| Mohamed, A | 1 |
| Thakkar, M | 1 |
| Rajula, A | 1 |
| Gatheru, J | 1 |
| Xue, Q | 1 |
| Deng, Y | 1 |
| Liu, Y | 1 |
| Wang, Y | 1 |
| Hu, W | 1 |
| Huang, Y | 1 |
| Yang, K | 1 |
| Alwan, SN | 1 |
| Taylor, AB | 1 |
| Rhodes, J | 1 |
| Tidwell, M | 1 |
| McHardy, SF | 1 |
| LoVerde, PT | 1 |
| Chami, GF | 1 |
| Kabatereine, NB | 2 |
| Tukahebwa, EM | 2 |
| Shen, Y | 1 |
| Sung, MH | 1 |
| King, CH | 3 |
| Binder, S | 4 |
| Kittur, N | 3 |
| Whalen, CC | 2 |
| Colley, DG | 4 |
| Mekete, K | 1 |
| Ower, A | 1 |
| Dunn, J | 1 |
| Sime, H | 1 |
| Tadesse, G | 2 |
| Abate, E | 1 |
| Nigussu, N | 1 |
| Seife, F | 1 |
| McNaughton, E | 1 |
| Anderson, RM | 1 |
| Phillips, AE | 2 |
| Wells, N | 1 |
| Chappuis, F | 1 |
| Beran, D | 1 |
| Lemos, M | 1 |
| Pedro, JM | 1 |
| Fançony, C | 1 |
| Moura, S | 1 |
| Brito, M | 1 |
| Nery, SV | 1 |
| Sousa, CP | 1 |
| Barros, H | 1 |
| Jacobson, JA | 1 |
| Fleming, FM | 2 |
| Matendechero, SH | 1 |
| Knopp, S | 1 |
| Rollinson, D | 2 |
| Utzinger, J | 2 |
| Castleman, JD | 2 |
| Campbell, CH | 2 |
| Kabole, FM | 1 |
| Kinung'hi, S | 1 |
| Ramzy, RMR | 1 |
| Bergquist, NR | 1 |
| Kinung'hi, SM | 1 |
| Olsen, A | 4 |
| Magnussen, P | 1 |
| Karanja, DMS | 1 |
| Mwinzi, PNM | 1 |
| Montgomery, SP | 1 |
| Secor, WE | 1 |
| Dhanani, N | 1 |
| Gazzinelli-Guimaraes, PH | 1 |
| Clements, MN | 1 |
| N'Goran, EK | 1 |
| Meite, A | 1 |
| Hamidou, AA | 1 |
| Garba, A | 1 |
| Spangenberg, T | 1 |
| Yu, Q | 1 |
| Xiao, N | 1 |
| Han, S | 1 |
| Tian, T | 1 |
| Zhou, XN | 1 |
| McCusker, P | 1 |
| Rohr, CM | 1 |
| Chan, JD | 1 |
| Onasanya, A | 1 |
| Bengtson, M | 1 |
| Oladepo, O | 1 |
| Van Engelen, J | 1 |
| Diehl, JC | 1 |
| Siqueira, LDP | 1 |
| Fontes, DAF | 1 |
| Aguilera, CSB | 1 |
| Timóteo, TRR | 1 |
| Ângelos, MA | 1 |
| de Melo, CG | 1 |
| da Silva, RMF | 1 |
| Neto, PJR | 1 |
| Shiff, C | 1 |
| Cohee, LM | 1 |
| Chilombe, M | 1 |
| Ngwira, A | 1 |
| Jemu, SK | 1 |
| Mathanga, DP | 1 |
| Laufer, MK | 1 |
| Velasco-Tirado, V | 1 |
| Alonso-Sardón, M | 1 |
| Lopez-Bernus, A | 1 |
| Romero-Alegría, Á | 1 |
| Burguillo, FJ | 1 |
| Muro, A | 1 |
| Carpio-Pérez, A | 1 |
| Muñoz Bellido, JL | 1 |
| Pardo-Lledias, J | 1 |
| Cordero, M | 1 |
| Belhassen-García, M | 1 |
| Stroehlein, AJ | 1 |
| Gasser, RB | 1 |
| Hall, RS | 1 |
| Young, ND | 1 |
| Kemal, M | 1 |
| Esmael, A | 1 |
| Abay, SM | 1 |
| Kebede, T | 1 |
| Cavalcanti, MG | 1 |
| Cunha, AFA | 1 |
| Peralta, JM | 1 |
| Li, L | 1 |
| Liu, X | 1 |
| Zhou, B | 1 |
| Zhang, S | 1 |
| Wang, G | 1 |
| Ma, G | 1 |
| Chen, R | 1 |
| Zou, Y | 1 |
| Cao, W | 1 |
| Li, T | 1 |
| Greenberg, RM | 1 |
| Muhumuza, S | 2 |
| Nuwaha, F | 3 |
| Katahoire, A | 2 |
| Samuel, MI | 1 |
| Taylor, C | 1 |
| Ross, AG | 1 |
| Olveda, RM | 1 |
| Li, Y | 1 |
| Nordin, P | 1 |
| Poggensee, G | 1 |
| Mtweve, S | 1 |
| Krantz, I | 1 |
| Nalugwa, A | 1 |
| de Campos, VE | 1 |
| Silva, JA | 1 |
| Ricci-Júnior, E | 1 |
| Mansur, CR | 1 |
| Conti, DS | 1 |
| da Rocha, SR | 1 |
| Savioli, L | 1 |
| Fenwick, A | 3 |
| Albonico, M | 1 |
| Ame, SM | 1 |
| Trainor-Moss, S | 1 |
| Mutapi, F | 1 |
| Bogus, J | 1 |
| Gankpala, L | 1 |
| Fischer, K | 1 |
| Krentel, A | 1 |
| Weil, GJ | 1 |
| Fischer, PU | 1 |
| Kollie, K | 1 |
| Bolay, FK | 1 |
| Namatame, I | 1 |
| Jourdan, P | 1 |
| Laursen, L | 1 |
| Ghasemi, R | 1 |
| Rowe, A | 1 |
| Shah, R | 1 |
| Venkatesan, P | 1 |
| England, TJ | 1 |
| Musselwhite, LW | 1 |
| Maciag, K | 1 |
| Lankowski, A | 1 |
| Gretes, MC | 1 |
| Wellems, TE | 1 |
| Tavera, G | 1 |
| Goulding, RE | 1 |
| Guillen, E | 1 |
| Evans, D | 1 |
| McFarland, D | 1 |
| Adamani, W | 1 |
| Eigege, A | 1 |
| Miri, E | 1 |
| Schulz, J | 1 |
| Pede, E | 1 |
| Umbugadu, C | 1 |
| Ogbu-Pearse, P | 1 |
| Richards, FO | 1 |
| Navaratnam, AM | 1 |
| Sousa-Figueiredo, JC | 1 |
| Stothard, JR | 1 |
| Mutumba-Nakalembe, MJ | 1 |
| McManus, DP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Commerical Antibody Tests for COVID-19[NCT04360954] | 461 participants (Actual) | Observational | 2020-04-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for praziquantel and Neglected Diseases
| Article | Year |
|---|---|
Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
Topics: Animals; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Humans; Molecular Structure; N | 2017 |
Drug associations as alternative and complementary therapy for neglected tropical diseases.
Topics: Complementary Therapies; Humans; Neglected Diseases; Pharmaceutical Preparations; Praziquantel; Schi | 2022 |
The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.
Topics: Animals; Neglected Diseases; Praziquantel; Schistosoma; Schistosomiasis; Vaccines | 2022 |
Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel.
Topics: Anthelmintics; Diabetes Mellitus; Global Health; Health Services Accessibility; Humans; Hypoglycemic | 2020 |
Schistosomiasis Consortium for Operational Research and Evaluation (SCORE): Its Foundations, Development, and Evolution.
Topics: Animals; Disease Reservoirs; Disease Vectors; History, 21st Century; Humans; Mass Drug Administratio | 2020 |
Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research.
Topics: Africa; Animals; Anthelmintics; Antigens, Helminth; Biomarkers; Child; Feces; Glycoproteins; Health | 2020 |
Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting.
Topics: Africa; Animals; Anthelmintics; Child; Child, Preschool; Female; Humans; Male; Mass Drug Administrat | 2020 |
Schistosomiasis: Drugs used and treatment strategies.
Topics: Animals; Anthelmintics; Biomedical Research; Brazil; Child; Female; Humans; Neglected Diseases; Oxam | 2017 |
Medical treatment of cystic echinococcosis: systematic review and meta-analysis.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Databases, Factual; Drug Therapy, Combination; Echinococ | 2018 |
The Advances in Molecular and New Point-of-Care (POC) Diagnosis of Schistosomiasis Pre- and Post-praziquantel Use: In the Pursuit of More Reliable Approaches for Low Endemic and Non-endemic Areas.
Topics: Anthelmintics; Antigens, Helminth; Humans; Neglected Diseases; Point-of-Care Systems; Praziquantel; | 2019 |
Multiple food-borne trematodiases with profound systemic involvement: a case report and literature review.
Topics: Adult; Animals; Anthelmintics; Fishes; Food Parasitology; Foodborne Diseases; Humans; Male; Neglecte | 2019 |
New approaches for understanding mechanisms of drug resistance in schistosomes.
Topics: Animals; ATP-Binding Cassette Transporters; Chromosome Mapping; Drug Resistance; Genomics; Helminth | 2013 |
[Activity of NTDs Drug-discovery Research Consortium].
Topics: Antiprotozoal Agents; Drug Compounding; Drug Discovery; Health Services Accessibility; Humans; Negle | 2016 |
4 trials available for praziquantel and Neglected Diseases
| Article | Year |
|---|---|
Modeling Approaches to Predicting Persistent Hotspots in SCORE Studies for Gaining Control of Schistosomiasis Mansoni in Kenya and Tanzania.
Topics: Animals; Anthelmintics; Child; Feasibility Studies; Feces; Female; Humans; Kenya; Male; Mass Drug Ad | 2020 |
Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.
Topics: Age Factors; Animals; Anthelmintics; Child, Preschool; Female; Humans; Infant; Male; Neglected Disea | 2015 |
Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial.
Topics: Abdominal Pain; Adolescent; Child; Cross-Sectional Studies; Demography; Diarrhea; Dizziness; Eating; | 2015 |
Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety.
Topics: Anthelmintics; Child, Preschool; Feces; Female; Follow-Up Studies; Humans; Male; Neglected Diseases; | 2012 |
33 other studies available for praziquantel and Neglected Diseases
| Article | Year |
|---|---|
[Introduction of "Access to Health" Initiatives for Neglected Tropical Diseases (NTDs)～R&D of NTD Medicines～].
Topics: Child; Drug Discovery; Humans; Neglected Diseases; Praziquantel; Tropical Medicine | 2022 |
Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects.
Topics: Adult; Aldehyde Dehydrogenase; Animals; Disulfiram; Humans; Neglected Diseases; Nitrogen; Oxamniquin | 2022 |
Prevalence and factors associated with transmission of schistosomiasis in school-aged children in South Sudan: a cross-sectional study.
Topics: Adolescent; Animals; Child; Child, Preschool; Cross-Sectional Studies; Feces; Female; Humans; Male; | 2022 |
Colonic polyps: a rare clinical manifestation of schistosomiasis (a case report).
Topics: Animals; Colonic Polyps; Colonoscopy; Male; Neglected Diseases; Praziquantel; Schistosoma mansoni; S | 2022 |
A retrospective analysis of schistosomiasis related literature from 2011-2020: Focusing on the next decade.
Topics: Animals; Bibliometrics; Humans; Neglected Diseases; Praziquantel; Retrospective Studies; Schistosoma | 2023 |
Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
Topics: Animals; Anthelmintics; Combined Modality Therapy; Humans; Neglected Diseases; Oxamniquine; Praziqua | 2023 |
The division of labour between community medicine distributors influences the reach of mass drug administration: A cross-sectional study in rural Uganda.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Community Hea | 2019 |
The Geshiyaro Project: a study protocol for developing a scalable model of interventions for moving towards the interruption of the transmission of soil-transmitted helminths and schistosome infections in the Wolaita zone of Ethiopia.
Topics: Adolescent; Albendazole; Anthelmintics; Child; Child, Preschool; Cost-Benefit Analysis; Cross-Sectio | 2019 |
Schistosomiasis and soil-transmitted helminthiasis preventive chemotherapy: Adverse events in children from 2 to 15 years in Bengo province, Angola.
Topics: Adolescent; Albendazole; Angola; Animals; Anthelmintics; Child; Child, Preschool; Coinfection; Feces | 2020 |
Schistosomiasis Consortium for Operational Research and Evaluation: Mission Accomplished.
Topics: Africa South of the Sahara; Animals; Anthelmintics; Chemoprevention; Cost-Benefit Analysis; Disease | 2020 |
Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis.
Topics: Anthelmintics; Humans; Neglected Diseases; Praziquantel; Schistosomiasis | 2021 |
Progress on the national echinococcosis control programme in China: analysis of humans and dogs population intervention during 2004-2014.
Topics: Albendazole; Animals; Anthelmintics; China; Dog Diseases; Dogs; Echinococcosis; Echinococcus; Humans | 2020 |
Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure.
Topics: Animals; Anthelmintics; Female; Liver; Mice; Neglected Diseases; Praziquantel; Schistosoma mansoni; | 2021 |
Rethinking the Top-Down Approach to Schistosomiasis Control and Elimination in Sub-Saharan Africa.
Topics: Africa South of the Sahara; Humans; Mass Drug Administration; Neglected Diseases; Praziquantel; Schi | 2021 |
Why reinvent the wheel? Lessons in schistosomiasis control from the past.
Topics: Africa; Animals; Congresses as Topic; Disease Eradication; Disease Vectors; Humans; Molluscacides; N | 2017 |
Pilot Study of the Addition of Mass Treatment for Malaria to Existing School-Based Programs to Treat Neglected Tropical Diseases.
Topics: Adolescent; Albendazole; Anthelmintics; Antimalarials; Artemether, Lumefantrine Drug Combination; Ch | 2018 |
Schistosomiasis.
Topics: Animals; Anthelmintics; Humans; Neglected Diseases; Praziquantel; Quality of Life; Schistosomiasis; | 2018 |
Interactive online application for the prediction, ranking and prioritisation of drug targets in Schistosoma haematobium.
Topics: Animals; Anthelmintics; Computational Biology; Drug Delivery Systems; Genomics; Humans; Ligands; Mol | 2018 |
Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel.
Topics: Animals; Anthelmintics; Child; Child, Preschool; Ethiopia; Feces; Female; Humans; Longitudinal Studi | 2019 |
Understanding low uptake of mass treatment for intestinal schistosomiasis among school children: a qualitative study in Jinja district, Uganda.
Topics: Adolescent; Child; Cross-Sectional Studies; Faculty; Female; Focus Groups; Humans; Interviews as Top | 2015 |
A case of female urogenital schistosomiasis presenting as viral warts.
Topics: Adult; Animals; Anthelmintics; Biopsy; Female; Humans; Malawi; Neglected Diseases; Praziquantel; Sch | 2015 |
An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration.
Topics: Anthelmintics; Disease Eradication; Humans; Neglected Diseases; Practice Guidelines as Topic; Praziq | 2015 |
From a weighing scale to a pole: a comparison of two different dosage strategies in mass treatment of Schistosomiasis haematobium.
Topics: Adolescent; Body Height; Body Weight; Child; Drug Dosage Calculations; Female; Humans; Male; Neglect | 2014 |
Polymeric Nanostructured Systems for Liquid Formulation of Praziquan-tel: Development and in vitro Assessment.
Topics: Administration, Oral; Anthelmintics; Biological Availability; Caco-2 Cells; Chemistry, Pharmaceutica | 2016 |
An achievable goal: control and elimination of schistosomiasis.
Topics: Anthelmintics; Disease Eradication; Humans; Neglected Diseases; Praziquantel; Schistosomiasis | 2015 |
Schistosomiasis therapeutics: whats in the pipeline?
Topics: Animals; Drug Design; Female; Humans; Neglected Diseases; Praziquantel; Schistosoma; Schistosomiasis | 2016 |
Community Attitudes Toward Mass Drug Administration for Control and Elimination of Neglected Tropical Diseases After the 2014 Outbreak of Ebola Virus Disease in Lofa County, Liberia.
Topics: Adult; Albendazole; Animals; Antiparasitic Agents; Data Collection; Disease Eradication; Disease Out | 2016 |
Schistosomiasis elimination by 2020 or 2030?
Topics: Anthelmintics; Disease Eradication; Global Health; Humans; Neglected Diseases; Praziquantel; Schisto | 2016 |
Tropical disease: A neglected cause.
Topics: Access to Information; Biomedical Research; Drug Discovery; Drug Industry; Humans; Information Disse | 2016 |
Neurocysticercosis presenting as a 'Stroke Mimic'.
Topics: Albendazole; Anticestodal Agents; Brain; Diagnosis, Differential; Glucocorticoids; Humans; Magnetic | 2016 |
First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium.
Topics: Access to Information; Animals; Anthelmintics; Biomedical Research; Developing Countries; Drug Indus | 2012 |
Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria.
Topics: Adolescent; Adult; Albendazole; Antiparasitic Agents; Child; Cost-Benefit Analysis; Drug Administrat | 2011 |
Schistosomiasis in 2012: current status and key research priorities required for control leading to elimination.
Topics: Anthelmintics; Biomedical Research; Humans; Neglected Diseases; Praziquantel; Schistosomiasis | 2012 |